GLAXF - GlaxoSmithKline plc

Other OTC - Other OTC Delayed price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts221413
Avg. Estimate0.430.571.791.91
Low estimate0.40.571.51.64
High estimate0.460.581.882.06
Year ago EPS0.40.571.721.79
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts331313
Avg. Estimate8.46B9.56B35.82B37.96B
Low estimate8.34B9.52B35.45B36.87B
High estimate8.58B9.6B36.54B39.26B
Year ago sales8.1B9.44B36.03B35.82B
Sales growth (year/est)4.40%1.20%-0.60%6.00%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS0.340.480.260.42
Actual EPS0.40.570.320.46
Difference0.060.090.060.04
Surprise %17.60%18.70%23.10%9.50%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate0.430.571.791.91
7 days ago0.460.581.791.92
30 days ago0.450.571.811.94
60 days ago0.450.581.81.9
90 days ago0.440.561.741.86
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/A111
Up last 30 daysN/A145
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/AN/AN/A
Growth estimatesGLAXFIndustrySector(s)S&P 500
Current qtr.7.50%N/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year4.10%N/AN/AN/A
Next year6.70%N/AN/AN/A
Next 5 years (per annum)0.09%N/AN/AN/A
Past 5 years (per annum)-1.21%N/AN/AN/A